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Majority of oral cancers develop from potentially malignant 
lesions. The malignant transformation rates of oral premalignant 
lesions are reported to be 1-7% for homogeneous, thick 
leukoplakia, 4-15% for granular or verruciform leukoplakia, 
18-47% for erythroleukoplakia, 4-11% for moderate dysplasia, 
and 20-35% for severe dysplasia.[1] The high rate of malignant 
transformation for potentially malignant lesions also indicates 
the importance of early diagnosis and early treatment.
Most of the potentially malignant lesions are 
non-homogeneous in nature. Hyperkeratosis and acanthosis may 
be present in one part of the lesion while others areas may show 
epithelial dysplasia, carcinoma in situ, or invasive carcinoma.
This mandates the need for multiple biopsies on several 
occasions. To alleviate patients’ anxiety from undergoing 
multiple procedures one of the best non-invasive ways to 
help choose the appropriate site for biopsy is to use the optic 
coherence tomography (OCT) to detect oral precancers and 
cancers.[2]
OCT was fi rst reported by Fujimoto et al. in 1991.[3] It has 
been widely used in numerous clinical applications including 
dermatology and dentistry. OCT is a non-invasive, optical 
diagnostic tool based on interferometers. It uses a low-coherence 
broadband near-infrared light source and obtains an excellent 
spatial resolution (~20 μm) and real-time images. It was fi rst 
used in vitro in human retina and atherosclerotic plaque cases.[4-7]
Tsai et al. utilized swept-source - OCT to diﬀ erentiate various 
lesions including mild dysplasia, moderate dysplasia, early-stage 
squamous cell carcinoma, and well-developed SCC.[8]
Cancer biology and drug response in preclinical settings 
have been evaluated by researchers using OCT. A signifi cant 
application of OCT in preclinical cancer research has been in 
the fi eld of angiography. The ability of OCT to repeatedly image 
over broad fi elds makes it ideal for studies of tumor angiogenesis 
and vascular response across a variety of sites.[9]
OCT has also been employed to characterize angiogenesis 
in xenograft models.[10] In a further example of hybrid studies 
combining OCT with other modalities, an instrument capable of 
dynamically imaging oxygen supply and demand in tumors has 
been demonstrated.[11]
As OCT can pinpoint epithelial changes, this imaging tool 
has sought potential broad applications in other mucosal lesions 
such as vesicullo bullous and vascular lesions. The possibility of 
this application for bone-related disease imaging is an interesting 
research prospect. Future research should focus on the suitable 
wavelength of the light source of OCT for better observation 
of oral diseases.[12] Faster and higher resolution OCT systems 
may replace the need for biopsies in many situations in the near 
future.
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